perkinelmer inc
PerkinElmer Launches Vectra® Polaris™ Automated Quantitative Pathology Imaging System
The new platform helps research immuno-oncologists and pathologists accelerate the study of cancer.
PerkinElmer, NCDS To Advance Personalized Medicine In China
PerkinElmer, Inc. has announced a new collaboration with the National Center for Drug Screening to advance personalized medicine and drug profiling in China.
PerkinElmer Acquires Chinese Infectious Disease Diagnostics Company
PerkinElmer has acquired Shanghai Haoyuan Biotech to extend its reach into the growing Chinese nucleic acid-based blood screening market.
